Use of selective serotonin reuptake inhibitors (SSRIs) by pregnant women may increase the risk for autism spectrum disorder (ASD) in their offspring, new research suggests.
In a study of more than 1800 children, investigators found an adjusted 2-fold increased risk for ASD among mothers who used an SSRI during the year before delivery and a 3-fold increased risk when SSRIs were ingested during the first trimester.
"The potential association between use of antidepressants during pregnancy and risk of [ASDs] has never been investigated before," lead author Lisa A. Croen, PhD, senior research scientist and director of the Autism Research Program at Kaiser Permanente Northern California (KPNC) in Oakland, told Medscape Medical News.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment